Vanguard Group’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $35.8M | Sell |
3,802,646
-31,722
| -0.8% | -$299K | ﹤0.01% | 2278 |
|
2025
Q1 | $20.8M | Buy |
3,834,368
+31,141
| +0.8% | +$169K | ﹤0.01% | 2489 |
|
2024
Q4 | $28.3M | Buy |
3,803,227
+755,045
| +25% | +$5.63M | ﹤0.01% | 2416 |
|
2024
Q3 | $24.4M | Buy |
3,048,182
+273,728
| +10% | +$2.19M | ﹤0.01% | 2500 |
|
2024
Q2 | $24.1M | Buy |
2,774,454
+378,226
| +16% | +$3.29M | ﹤0.01% | 2472 |
|
2024
Q1 | $49.5M | Buy |
2,396,228
+362,168
| +18% | +$7.49M | ﹤0.01% | 2170 |
|
2023
Q4 | $47M | Buy |
2,034,060
+593,336
| +41% | +$13.7M | ﹤0.01% | 2212 |
|
2023
Q3 | $11.5M | Buy |
1,440,724
+37,486
| +3% | +$300K | ﹤0.01% | 2809 |
|
2023
Q2 | $12.2M | Buy |
1,403,238
+4,205
| +0.3% | +$36.6K | ﹤0.01% | 2826 |
|
2023
Q1 | $4.11M | Buy |
1,399,033
+3,447
| +0.2% | +$10.1K | ﹤0.01% | 3395 |
|
2022
Q4 | $4.88M | Sell |
1,395,586
-2,902
| -0.2% | -$10.2K | ﹤0.01% | 3321 |
|
2022
Q3 | $11.1M | Buy |
1,398,488
+43,170
| +3% | +$341K | ﹤0.01% | 2914 |
|
2022
Q2 | $10.7M | Buy |
1,355,318
+122,517
| +10% | +$964K | ﹤0.01% | 2959 |
|
2022
Q1 | $15M | Buy |
1,232,801
+43,831
| +4% | +$533K | ﹤0.01% | 2932 |
|
2021
Q4 | $14.6M | Buy |
1,188,970
+96,664
| +9% | +$1.18M | ﹤0.01% | 3016 |
|
2021
Q3 | $11.4M | Buy |
1,092,306
+5,977
| +0.6% | +$62.3K | ﹤0.01% | 3162 |
|
2021
Q2 | $9.77M | Buy |
1,086,329
+181,890
| +20% | +$1.64M | ﹤0.01% | 3211 |
|
2021
Q1 | $9.19M | Buy |
904,439
+582,736
| +181% | +$5.92M | ﹤0.01% | 3193 |
|
2020
Q4 | $2.12M | Sell |
321,703
-27
| -0% | -$178 | ﹤0.01% | 3646 |
|
2020
Q3 | $1.67M | Sell |
321,730
-8,046
| -2% | -$41.7K | ﹤0.01% | 3536 |
|
2020
Q2 | $2.5M | Sell |
329,776
-20,467
| -6% | -$155K | ﹤0.01% | 3368 |
|
2020
Q1 | $3.57M | Buy |
350,243
+50,369
| +17% | +$514K | ﹤0.01% | 3115 |
|
2019
Q4 | $4.65M | Sell |
299,874
-914
| -0.3% | -$14.2K | ﹤0.01% | 3195 |
|
2019
Q3 | $5.44M | Buy |
300,788
+32,459
| +12% | +$587K | ﹤0.01% | 3109 |
|
2019
Q2 | $4.4M | Sell |
268,329
-10,477
| -4% | -$172K | ﹤0.01% | 3211 |
|
2019
Q1 | $4.99M | Buy |
278,806
+26,024
| +10% | +$466K | ﹤0.01% | 3141 |
|
2018
Q4 | $4.78M | Buy |
252,782
+72,911
| +41% | +$1.38M | ﹤0.01% | 3107 |
|
2018
Q3 | $6.42M | Buy |
179,871
+4,736
| +3% | +$169K | ﹤0.01% | 3139 |
|
2018
Q2 | $3.64M | Buy |
175,135
+7,542
| +5% | +$157K | ﹤0.01% | 3316 |
|
2018
Q1 | $2.05M | Buy |
167,593
+10,797
| +7% | +$132K | ﹤0.01% | 3457 |
|
2017
Q4 | $1.69M | Buy |
156,796
+44,589
| +40% | +$481K | ﹤0.01% | 3475 |
|
2017
Q3 | $1.35M | Buy |
112,207
+2,315
| +2% | +$27.8K | ﹤0.01% | 3512 |
|
2017
Q2 | $1.88M | Sell |
109,892
-4,688
| -4% | -$80.2K | ﹤0.01% | 3400 |
|
2017
Q1 | $1.97M | Buy |
114,580
+3,889
| +4% | +$66.9K | ﹤0.01% | 3386 |
|
2016
Q4 | $1.89M | Buy |
110,691
+12,579
| +13% | +$215K | ﹤0.01% | 3378 |
|
2016
Q3 | $2.95M | Buy |
98,112
+2,738
| +3% | +$82.4K | ﹤0.01% | 3236 |
|
2016
Q2 | $2.7M | Buy |
95,374
+1,287
| +1% | +$36.4K | ﹤0.01% | 3255 |
|
2016
Q1 | $2.52M | Buy |
94,087
+18,509
| +24% | +$496K | ﹤0.01% | 3293 |
|
2015
Q4 | $3.64M | Buy |
75,578
+2,110
| +3% | +$102K | ﹤0.01% | 3130 |
|
2015
Q3 | $2.68M | Buy |
73,468
+1,523
| +2% | +$55.6K | ﹤0.01% | 3242 |
|
2015
Q2 | $2.71M | Buy |
71,945
+1,210
| +2% | +$45.6K | ﹤0.01% | 3294 |
|
2015
Q1 | $2.79M | Buy |
70,735
+4,509
| +7% | +$178K | ﹤0.01% | 3272 |
|
2014
Q4 | $2.72M | Buy |
66,226
+2,018
| +3% | +$82.9K | ﹤0.01% | 3166 |
|
2014
Q3 | $2.84M | Buy |
64,208
+2,833
| +5% | +$125K | ﹤0.01% | 3120 |
|
2014
Q2 | $2.66M | Hold |
61,375
| – | – | ﹤0.01% | 3132 |
|
2014
Q1 | $2.52M | Buy |
61,375
+18,185
| +42% | +$745K | ﹤0.01% | 3119 |
|
2013
Q4 | $1.72M | Buy |
43,190
+6,054
| +16% | +$240K | ﹤0.01% | 3248 |
|
2013
Q3 | $1.53M | Buy |
37,136
+3,091
| +9% | +$127K | ﹤0.01% | 3241 |
|
2013
Q2 | $1.32M | Buy |
+34,045
| New | +$1.32M | ﹤0.01% | 3219 |
|